Context Therapeutics Inc.CNTXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-29.31M
↓ 127% below average
Average (5y)
$-12.89M
Historical baseline
Range
High:$-1.03M
Low:$-29.31M
CAGR
+59.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-29.31M | -39.3% |
| 2023 | $-21.05M | -49.4% |
| 2022 | $-14.09M | -55.7% |
| 2021 | $-9.05M | -774.7% |
| 2020 | $-1.03M | +63.5% |
| 2019 | $-2.84M | - |